Dabigatran Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: D76F61278F48EN
Market Monitor Global

Abstracts

Dabigatran is an innovative anticoagulant, a new generation of thin blood drugs, known as the best drug for prevention of stroke in the past 60 years.

This report contains market size and forecasts of Dabigatran in Global, including the following market information:

Global Dabigatran Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dabigatran market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dabigatran include Pfizer, Bayer Healthcare, GlaxoSmithKline, Boehringer Ingelheim, Aspen Holdings, Bristol-Myers Squibb Company and Teva Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dabigatran companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dabigatran Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dabigatran Market Segment Percentages, by Type, 2021 (%)

• Tablets
• Capsule
• Others

Global Dabigatran Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dabigatran Market Segment Percentages, by Application, 2021 (%)

• Deep Vein Thrombosis
• Pulmonary Embolism
• Others

Global Dabigatran Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dabigatran Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dabigatran revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dabigatran revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Bayer Healthcare
• GlaxoSmithKline
• Boehringer Ingelheim
• Aspen Holdings
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dabigatran Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dabigatran Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DABIGATRAN OVERALL MARKET SIZE

2.1 Global Dabigatran Market Size: 2021 VS 2028
2.2 Global Dabigatran Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dabigatran Players in Global Market
3.2 Top Global Dabigatran Companies Ranked by Revenue
3.3 Global Dabigatran Revenue by Companies
3.4 Top 3 and Top 5 Dabigatran Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dabigatran Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dabigatran Players in Global Market
  3.6.1 List of Global Tier 1 Dabigatran Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dabigatran Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dabigatran Market Size Markets, 2021 & 2028
  4.1.2 Tablets
  4.1.3 Capsule
  4.1.4 Others
4.2 By Type - Global Dabigatran Revenue & Forecasts
  4.2.1 By Type - Global Dabigatran Revenue, 2017-2022
  4.2.2 By Type - Global Dabigatran Revenue, 2023-2028
  4.2.3 By Type - Global Dabigatran Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dabigatran Market Size, 2021 & 2028
  5.1.2 Deep Vein Thrombosis
  5.1.3 Pulmonary Embolism
  5.1.4 Others
5.2 By Application - Global Dabigatran Revenue & Forecasts
  5.2.1 By Application - Global Dabigatran Revenue, 2017-2022
  5.2.2 By Application - Global Dabigatran Revenue, 2023-2028
  5.2.3 By Application - Global Dabigatran Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dabigatran Market Size, 2021 & 2028
6.2 By Region - Global Dabigatran Revenue & Forecasts
  6.2.1 By Region - Global Dabigatran Revenue, 2017-2022
  6.2.2 By Region - Global Dabigatran Revenue, 2023-2028
  6.2.3 By Region - Global Dabigatran Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dabigatran Revenue, 2017-2028
  6.3.2 US Dabigatran Market Size, 2017-2028
  6.3.3 Canada Dabigatran Market Size, 2017-2028
  6.3.4 Mexico Dabigatran Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dabigatran Revenue, 2017-2028
  6.4.2 Germany Dabigatran Market Size, 2017-2028
  6.4.3 France Dabigatran Market Size, 2017-2028
  6.4.4 U.K. Dabigatran Market Size, 2017-2028
  6.4.5 Italy Dabigatran Market Size, 2017-2028
  6.4.6 Russia Dabigatran Market Size, 2017-2028
  6.4.7 Nordic Countries Dabigatran Market Size, 2017-2028
  6.4.8 Benelux Dabigatran Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dabigatran Revenue, 2017-2028
  6.5.2 China Dabigatran Market Size, 2017-2028
  6.5.3 Japan Dabigatran Market Size, 2017-2028
  6.5.4 South Korea Dabigatran Market Size, 2017-2028
  6.5.5 Southeast Asia Dabigatran Market Size, 2017-2028
  6.5.6 India Dabigatran Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dabigatran Revenue, 2017-2028
  6.6.2 Brazil Dabigatran Market Size, 2017-2028
  6.6.3 Argentina Dabigatran Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dabigatran Revenue, 2017-2028
  6.7.2 Turkey Dabigatran Market Size, 2017-2028
  6.7.3 Israel Dabigatran Market Size, 2017-2028
  6.7.4 Saudi Arabia Dabigatran Market Size, 2017-2028
  6.7.5 UAE Dabigatran Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Dabigatran Major Product Offerings
  7.1.4 Pfizer Dabigatran Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Bayer Healthcare
  7.2.1 Bayer Healthcare Corporate Summary
  7.2.2 Bayer Healthcare Business Overview
  7.2.3 Bayer Healthcare Dabigatran Major Product Offerings
  7.2.4 Bayer Healthcare Dabigatran Revenue in Global Market (2017-2022)
  7.2.5 Bayer Healthcare Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Dabigatran Major Product Offerings
  7.3.4 GlaxoSmithKline Dabigatran Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Boehringer Ingelheim
  7.4.1 Boehringer Ingelheim Corporate Summary
  7.4.2 Boehringer Ingelheim Business Overview
  7.4.3 Boehringer Ingelheim Dabigatran Major Product Offerings
  7.4.4 Boehringer Ingelheim Dabigatran Revenue in Global Market (2017-2022)
  7.4.5 Boehringer Ingelheim Key News
7.5 Aspen Holdings
  7.5.1 Aspen Holdings Corporate Summary
  7.5.2 Aspen Holdings Business Overview
  7.5.3 Aspen Holdings Dabigatran Major Product Offerings
  7.5.4 Aspen Holdings Dabigatran Revenue in Global Market (2017-2022)
  7.5.5 Aspen Holdings Key News
7.6 Bristol-Myers Squibb Company
  7.6.1 Bristol-Myers Squibb Company Corporate Summary
  7.6.2 Bristol-Myers Squibb Company Business Overview
  7.6.3 Bristol-Myers Squibb Company Dabigatran Major Product Offerings
  7.6.4 Bristol-Myers Squibb Company Dabigatran Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Company Key News
7.7 Teva Pharmaceutical Industries
  7.7.1 Teva Pharmaceutical Industries Corporate Summary
  7.7.2 Teva Pharmaceutical Industries Business Overview
  7.7.3 Teva Pharmaceutical Industries Dabigatran Major Product Offerings
  7.7.4 Teva Pharmaceutical Industries Dabigatran Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Industries Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dabigatran Market Opportunities & Trends in Global Market
Table 2. Dabigatran Market Drivers in Global Market
Table 3. Dabigatran Market Restraints in Global Market
Table 4. Key Players of Dabigatran in Global Market
Table 5. Top Dabigatran Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dabigatran Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dabigatran Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dabigatran Product Type
Table 9. List of Global Tier 1 Dabigatran Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dabigatran Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dabigatran Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dabigatran Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dabigatran Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dabigatran Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dabigatran Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dabigatran Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dabigatran Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dabigatran Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dabigatran Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dabigatran Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dabigatran Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dabigatran Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dabigatran Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dabigatran Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dabigatran Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dabigatran Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dabigatran Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dabigatran Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dabigatran Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Dabigatran Product Offerings
Table 32. Pfizer Dabigatran Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Healthcare Corporate Summary
Table 34. Bayer Healthcare Dabigatran Product Offerings
Table 35. Bayer Healthcare Dabigatran Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Dabigatran Product Offerings
Table 38. GlaxoSmithKline Dabigatran Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Dabigatran Product Offerings
Table 41. Boehringer Ingelheim Dabigatran Revenue (US$, Mn), (2017-2022)
Table 42. Aspen Holdings Corporate Summary
Table 43. Aspen Holdings Dabigatran Product Offerings
Table 44. Aspen Holdings Dabigatran Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Company Corporate Summary
Table 46. Bristol-Myers Squibb Company Dabigatran Product Offerings
Table 47. Bristol-Myers Squibb Company Dabigatran Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Industries Corporate Summary
Table 49. Teva Pharmaceutical Industries Dabigatran Product Offerings
Table 50. Teva Pharmaceutical Industries Dabigatran Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dabigatran Segment by Type in 2021
Figure 2. Dabigatran Segment by Application in 2021
Figure 3. Global Dabigatran Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dabigatran Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dabigatran Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dabigatran Revenue in 2021
Figure 8. By Type - Global Dabigatran Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dabigatran Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dabigatran Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dabigatran Revenue Market Share, 2017-2028
Figure 12. US Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dabigatran Revenue Market Share, 2017-2028
Figure 16. Germany Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 17. France Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dabigatran Revenue Market Share, 2017-2028
Figure 24. China Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 28. India Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dabigatran Revenue Market Share, 2017-2028
Figure 30. Brazil Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dabigatran Revenue Market Share, 2017-2028
Figure 33. Turkey Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dabigatran Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Healthcare Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aspen Holdings Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Company Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Industries Dabigatran Revenue Year Over Year Growth (US$, Mn) & (2017-2022)